P-064 - CT-GUIDED BRACHYTHERAPY IN ADVANCED CERVICAL CARCINOMA. OUR FIRST 100 PATIENTS.
P-065 - CUIDADOS DE ENFERMERÍA EN LA MUCOSITIS DEL PACIENTE ONCOLÓGICO
P-066 - CYTOREDUCTIVE THERAPY: THE OPTION PRIOR BRACHYTHERAPY FOR HIGH PROSTATE VOLUME?
P-067 - DAROL STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
P-068 - DAROLUTAMIDE IN NMCRPC PATIENTS WITH AND WITHOUT PRIOR LOCAL THERAPY
P-069 - Deep Inspiration Breath Hold dosimetry with VMAT in breast cancer
P-070 - DEEP INSPIRATION BREATH HOLD IN PATIENTS WITH LEFT BREAST CANCER
P-071 - DEFINING THE ROLE OF CHEST-WALL RADIOTHERAPY FOR IN-SITU BREAST CARCINOMA
P-072 - DEFINITIVE RADIOTHERAPY IN T1 GLOTTIC CARCINOMA: LONG-TERM RESULTS AND QUALITY-OF-LIFE
P-073 - DEVELOPMENT OF A TRACKING TOOL TO MONITOR TREATMENT PREPARATION TIMES
P-074 - DEVELOPMENT OF A USEFUL AND ACCESSIBLE INCIDENT NOTIFICATION SYSTEM
P-075 - DIFFERENCES IN THE APALUTAMIDE-RESPONSE ACCORDING TO THE LOCATION OF METASTASIS
P-077 - DOES ADVANCED IMAGING MODIFY RADIOTHERAPY IN EXCLUSIVE NODAL-OLIGORECURRENCE AFTER SURGERY?
P-079 - Dosimetric comparison using VMAT and helical tomotherapy in esophageal cancer
P-080 - DOSIMETRIC DISTRIBUTION OF IORT-50 INTRAOPERATIVE SYSTEM
P-081 - DOSIMETRIC FEASIBILITY OF 1-WEEK-WBRT FOR SYNCHRONOUS BILATERAL EARLY BREAST CANCER
P-082 - DOSIMETRIC IMPACT OF THE CHOICE OF NORMALIZATION ISODOSE IN SBRT
P-083 - DOSIMETRIC PARAMETERS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED WITH HELICAL-TOMOTHERAPY.
P-084 - DOSIMETRIC QUALITY IN THE TREATMENT OF MULTIPLE METASTASES WITH HYPERARC™
P-085 - DOSIMETRIC QUALITY OF PTV IN CLINICAL DOSIMETRY OF PLEURAL MESOTHELIOMA
P-086 - DURVALUMAB AFTER CHEMORADIOTHERAPY (CRT) IN UNRESECTABLE STAGE III NSCLC